Roivant Sciences
ROIV
ROIV
338 hedge funds and large institutions have $5.8B invested in Roivant Sciences in 2025 Q2 according to their latest regulatory filings, with 62 funds opening new positions, 115 increasing their positions, 110 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
4% more capital invested
Capital invested by funds: $5.58B → $5.8B (+$217M)
1.83% less ownership
Funds ownership: 77.55% → 75.72% (-1.8%)
28% less funds holding in top 10
Funds holding in top 10: 18 → 13 (-5)
Holders
338
Holding in Top 10
13
Calls
$87.5M
Puts
$11.1M
Top Buyers
| 1 | +$98.8M | |
| 2 | +$59.7M | |
| 3 | +$43.3M | |
| 4 |
PA
Perceptive Advisors
New York
|
+$37.5M |
| 5 |
O
OrbiMed
New York
|
+$31.3M |
Top Sellers
| 1 | -$410M | |
| 2 | -$133M | |
| 3 | -$92.4M | |
| 4 |
TCIM
TOMS Capital Investment Management
New York
|
-$41.3M |
| 5 |
TCM
Tyro Capital Management
Miami,
Florida
|
-$24.9M |
